Should the transaction complete, J&J will inherit Atraverse's radiofrequency system for simplifying access to the heart's left atrium.
The company, whose shares climbed nearly 8% Wednesday morning, also said a recent cyber incident has been contained and did not significantly affect first-quarter results.
The medical device giant acquired an AI-powered coronary assessment company for $585M and led a $100M strategic round for a pulmonary hypertension therapy pioneer.
Accelerating Clinical Milestones: Multi-Center Trials for BMI Systems Set for Mid-2026, Neuromodulation Pipeline Advances
